Pharma Novartis chief’s 2018 take-home pay suffers—not from Cohen but from low-grade returns

Pharma Novartis chief’s 2018 take-home pay suffers—not from Cohen but from low-grade returns

Source: 
Fierce Pharma
snippet: 

Novartis CEO Vas Narasimhan navigated through a tough and transitional year at the drugmaker, racking up almost $10 million in salary, incentive pay and equity awards for his efforts. But his 2018 take-home pay took a hit on longer-term shareholder returns that weren’t up to par.